Order Article Reprints

Imran M, Khan SA, Abida, Alshammari MK, Alkhaldi SM, Alshammari FN, Kamal M, Alam O, Asdaq SMB, Alzahrani AK, et al. Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature. Molecules. 2022; 27(9):2750. https://doi.org/10.3390/molecules27092750

Imran, Mohd, Shah Alam Khan, Abida, Mohammed Kanan Alshammari, Saif M. Alkhaldi, Fayez Nafea Alshammari, Mehnaz Kamal, Ozair Alam, Syed Mohammed Basheeruddin Asdaq, A. Khuzaim Alzahrani, and et al. 2022. "Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature" Molecules 27, no. 9: 2750. https://doi.org/10.3390/molecules27092750

Imran, M., Khan, S. A., Abida, Alshammari, M. K., Alkhaldi, S. M., Alshammari, F. N., Kamal, M., Alam, O., Asdaq, S. M. B., Alzahrani, A. K., & Jomah, S. (2022). Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature. Molecules, 27(9), 2750. https://doi.org/10.3390/molecules27092750